
-
Suspect in Charlie Kirk killing charged with murder
-
France duo out of Women's Rugby World Cup semi-final as bans upheld
-
Simeone backs Atletico to hurt 'extraordinary' Liverpool
-
IEA says more oil and gas investment may be needed
-
Sabrina Carpenter, Justin Bieber, Karol G to headline Coachella
-
Colombia halts US arms purchases in row over drug fight delisting
-
Nestle says chairman Paul Bulcke to step down
-
Isak set for Liverpool debut in Atletico Madrid Champions League clash
-
Malawi votes in economic gloom as two presidents battle for power
-
No info in files that Epstein trafficked women to others: FBI chief
-
Stocks slip, dollar down as Fed meets on rates
-
Faith Kipyegon: Supreme Kenyan champion and role model for mothers
-
Hollywood giants sue Chinese AI firm over copyright infringement
-
Bayern's Kane keen to rekindle London rivalry against Chelsea
-
Trump sues NYT for $15 bn in latest attack on media
-
IndyCar reveals 17-race 2026 season with March opening
-
Trump heads for landmark state visit with 'friend' King Charles
-
Kipyegon sparkles, Tinch's time away pays off with world gold
-
Kerr completes Kiwi world double after Beamish tonic
-
US Fed opens key meeting after Trump aide sworn in as governor
-
Tinch crowns atypical path to top with world hurdles gold
-
Masters deal with Amazon Prime boosts US TV coverage hours
-
Thyssenkrupp says India's Jindal Steel makes bid for steel business
-
Germans turn to health apps as insurers foot the bill
-
Robert Redford, Hollywood's golden boy with a Midas touch
-
US retail sales beat expectations in August despite tariffs
-
New Zealand's Kerr wins world men's high jump gold
-
American Cordell Tinch wins world 110m hurdles gold
-
Kenya's Kipyegon wins unprecedented fourth women's world 1,500m title
-
Suspect in Kirk killing to be charged in US court
-
Cinema legend Robert Redford dead at 89
-
Europe slow to match economic rivals US, China: Draghi
-
Rugby World Cup chiefs defend handling of Berthoumieu biting incident
-
'Like failing a math test': US teen Lutkenhaus schooled at worlds
-
Philippines says one injured in China Coast Guard water cannon attack
-
Kenya court seeks UK citizen's arrest over young mother's murder
-
Malawi votes for a new president as economic crisis bites
-
Barca to stay at Johan Cruyff stadium for Getafe clash
-
'We pulled the children out in pieces': Israel pummels Gaza City
-
Stocks diverge, dollar down as Fed meets on rates
-
Zandvoort, Singapore to host F1 sprints for first time in 2026
-
Afghan man gets life in prison for jihadist knife killing in Germany
-
Shipowner linked to giant Beirut port blast held in Bulgaria
-
E. Timor police clash with protesters over plan to buy vehicles for MPs
-
Israel launches ground assault on Gaza City
-
Malawi votes in battle of two presidents as economic crisis bites
-
2025 summer was Spain's warmest on record: weather agency
-
Gout of this world? Australian teen sprinter set for first real test
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
GSK | -0.37% | 40.15 | $ | |
JRI | -0.61% | 13.975 | $ | |
AZN | -0.22% | 77.877 | $ | |
SCS | -0.54% | 16.78 | $ | |
CMSD | 0.2% | 24.5 | $ | |
BCE | -1.65% | 23.305 | $ | |
RBGPF | 0% | 77.27 | $ | |
RELX | -0.35% | 46.695 | $ | |
BTI | -0.08% | 55.985 | $ | |
RIO | -0.37% | 63.485 | $ | |
VOD | -0.47% | 11.755 | $ | |
BP | 0.74% | 34.465 | $ | |
CMSC | 0.25% | 24.382 | $ | |
NGG | -0.65% | 71.161 | $ | |
RYCEF | -0.06% | 15.63 | $ | |
BCC | -4.13% | 81.745 | $ |

Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
A.Jones--AMWN